Cigna Stock Dives On Q4 Earnings Miss: 'We Are Taking Corrective Actions To Address These Near-Term Pressures'

Comments
Loading...
Zinger Key Points

Cigna Group CI reported fourth-quarter financial results before the market open on Thursday. Here’s a look at the key details from the quarter.

Q4 Earnings: Cigna reported fourth-quarter revenue of $65.68 billion, beating analyst estimates of $63.36 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of $6.64 per share, missing analyst estimates of $7.82 per share.

Total revenue was up 27% on a year-over-year basis. Pharmacy benefit services revenue totaled $30.27 billion, up from $20.55 million in the prior year’s quarter. Specialty care and services revenue came in at $23.47 billion, up from $19.97 billion year-over-year. Cigna Healthcare revenue totaled $13.33 billion, up from $13 billion year-over-year.

Adjusted income from operations declined 8% year-over-year, primarily driven by lower contributions from Cigna Healthcare due to higher stop loss medical costs.

“While higher medical costs in our stop loss product impacted fourth quarter earnings, we are taking corrective actions to address these near-term pressures and we are simultaneously taking steps to further advance our long-term growth strategy,” said David Cordani, chairman and CEO of The Cigna Group.

“Through a dynamic environment, we are continuing to focus on building a sustainable model for healthcare by addressing the areas that matter most to our patients and clients, including greater transparency, support, and value.”

Check This Out: UPS Q4 Earnings: Major Customer Volume Cut Raises Jitters, Stock Tanks

Cigna’s board approved an increase of $6 billion to the company’s share repurchase program, bringing its total authorization up to $10.3 billion.

Outlook: Cigna expects full-year 2025 revenue of at least $252 billion, versus estimates of $251.95 billion, according to Benzinga Pro. The company anticipates full-year adjusted earnings of at least $29.50 per share, versus estimates of $31.50 per share.

Management is currently discussing the quarter on a conference call with analysts and investors that kicked off at 8:30 a.m. ET.

CI Price Action: Cigna Group shares were down 11.1% at $269.63 at the time of publication Thursday, per Benzinga Pro.

Photo: Shutterstock.

CI Logo
CIThe Cigna Group
$330.400.96%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
52.97
Growth
66.74
Quality
44.26
Value
28.91
Price Trend
Short
Medium
Long
Got Questions? Ask
How will Cigna's earnings miss impact healthcare stocks?
Which healthcare companies could gain from Cigna's challenges?
What opportunities exist in pharmacy benefit services post-Cigna?
How might Cigna's share repurchase program affect investor sentiment?
Which medical cost management firms stand to benefit from Cigna's issues?
Could Cigna's long-term growth strategy attract new investors?
What implications does Cigna's revenue outlook have on healthcare ETFs?
Which competitors may capitalize on Cigna's short-term pressures?
How will Cigna's earnings correction actions affect investor confidence?
What sectors might react to Cigna's financial results?
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: